Cancer immunotherapy treatments harness the power of a patient’s own immune system to recognize and destroy cancer cells.
SITC Cancer Immunotherapy CONNECT is your hub to learn about cancer immunotherapy and its potential for the future. Download a variety of resources in our library and connect to other patients and healthcare professionals in our online community to learn more about this powerful new treatment option for cancer.
The use of this treatment dates back to the late 1800s; however, the science has never before experienced such positive momentum in improving the lives of patients with cancer as in recent years. As more immunotherapy treatments receive U.S. Food and Drug Administration (FDA) approval for a variety of cancer types, stay connected with SITC for up-to-date resources and education about immunotherapy for cancer treatment.
Be Part of the Breakthrough at the Charles River World Congress on Animal Models in Drug Discovery & Development. Boston | September 26-27, 2017 http://breakthroughs.criver.com/index.html ...
Use of mAb-based immunotherapies has resulted in major improvements in treatment of B-cell neoplasms, but patients can relapse, succumbing to the disease. An alternative approach that destroys ...
According to the cited pharma company document within, out of Hemel Hempstead, England, May 10, 2017, Dinutuximab beta, originally developed by the Vienna-based biotech company Apeiron Biologics ...
The European Commission has recently approved dinutuximab beta for high risk neuroblastoma patients over the age of 12 months, making it the only approved immunotherapy in Europe for this ...
View More Patient Resources
Launched in July of 2016, SITC presents the newest in a series of videos focusing on immunotherapy for NSCLC patients, the NSCLC Immunotherapy: Advancing HopeTM video provides an overview of the building blocks of the immune system and immunotherapy, while also highlighting some* of the available FDA approved immunotherapy treatments and potential side effects, and the importance of clinical trials.
For more than 30 years SITC (Society for Immunotherapy of Cancer) has been fighting for treatment and a cure for cancer through research and collaboration. SITC members all over the world are leading the charge against cancer. We’re traveling the globe to meet these thought leaders and demonstrate the crucial work that they’re doing to impact advances in both the science and clinical application of immunotherapy.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org